Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AstraZeneca Gross Margin 2011-2025 | AZN

Current and historical gross margin for AstraZeneca (AZN) over the last 10 years. The current gross profit margin for AstraZeneca as of June 30, 2025 is %.
AstraZeneca Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-06-30 $56.50B $45.98B 81.38%
2025-03-31 $54.98B $44.75B 81.39%
2024-12-31 $54.07B $43.87B 81.12%
2024-09-30 $51.21B $41.42B 80.88%
2024-06-30 $49.13B $40.33B 82.08%
2024-03-31 $47.61B $39.03B 81.98%
2023-12-31 $45.81B $37.54B 81.95%
2023-09-30 $45.00B $36.14B 80.31%
2023-06-30 $44.49B $34.74B 78.09%
2023-03-31 $43.84B $33.06B 75.40%
2022-12-31 $44.35B $31.96B 72.06%
2022-09-30 $45.15B $31.04B 68.74%
2022-06-30 $44.04B $29.15B 66.19%
2022-03-31 $41.49B $27.40B 66.05%
2021-12-31 $37.42B $24.98B 66.76%
2021-09-30 $32.82B $23.48B 71.55%
2021-06-30 $29.53B $22.58B 76.46%
2021-03-31 $27.58B $21.84B 79.18%
2020-12-31 $26.62B $21.32B 80.09%
2020-09-30 $25.87B $20.72B 80.09%
2020-06-30 $25.70B $20.57B 80.03%
2020-03-31 $25.25B $20.04B 79.36%
2019-12-31 $24.38B $19.46B 79.82%
2019-09-30 $24.14B $18.96B 78.54%
2019-06-30 $23.07B $18.09B 78.41%
2019-03-31 $22.40B $17.47B 77.99%
2018-12-31 $22.09B $17.15B 77.66%
2018-09-30 $21.45B $16.93B 78.91%
2018-06-30 $22.34B $17.72B 79.32%
2018-03-31 $22.24B $17.68B 79.50%
2017-12-31 $22.47B $18.15B 80.78%
2017-09-30 $22.27B $18.02B 80.91%
2017-06-30 $21.74B $17.84B 82.04%
2017-03-31 $22.29B $18.28B 81.98%
2016-12-31 $23.00B $18.88B 82.06%
2016-09-30 $23.82B $19.58B 82.22%
2016-06-30 $24.06B $19.69B 81.81%
2016-03-31 $24.77B $20.39B 82.31%
2015-12-31 $24.71B $20.06B 81.20%
2015-09-30 $25.03B $19.98B 79.84%
2015-06-30 $25.69B $20.27B 78.91%
2015-03-31 $26.14B $20.49B 78.36%
2014-12-31 $26.55B $20.71B 77.99%
2014-09-30 $26.77B $21.16B 79.03%
2014-06-30 $26.41B $20.97B 79.41%
2014-03-31 $25.88B $20.43B 78.95%
2013-12-31 $25.81B $20.55B 79.61%
2013-09-30 $26.15B $20.93B 80.04%
2013-06-30 $26.58B $21.33B 80.23%
2013-03-31 $27.01B $21.73B 80.44%
2012-12-31 $27.97B $22.58B 80.72%
2012-09-30 $29.35B $23.74B 80.89%
2012-06-30 $30.88B $24.95B 80.81%
2012-03-31 $32.65B $26.59B 81.43%
2011-12-31 $33.59B $27.57B 82.06%
2011-09-30 $33.55B $27.38B 81.60%
2011-06-30 $33.24B $27.13B 81.63%
2011-03-31 $32.99B $26.91B 81.59%
2010-12-31 $33.27B $26.88B 80.80%
2010-09-30 $33.60B $27.30B 81.26%
2010-06-30 $33.90B $27.87B 82.20%
2010-03-31 $33.68B $27.63B 82.05%
2009-12-31 $32.80B $27.03B 82.40%
2009-09-30 $32.05B $25.83B 80.59%
2009-06-30 $31.63B $25.14B 79.49%
2009-03-31 $31.63B $25.15B 79.51%
2008-12-31 $31.60B $25.00B 79.12%
2008-09-30 $31.58B $27.09B 85.79%
2008-06-30 $30.95B $28.00B 90.45%
2008-03-31 $30.30B $27.13B 89.54%
2007-12-31 $29.59B $26.43B 89.34%
2007-09-30 $28.57B $23.84B 83.44%
2007-06-30 $27.94B $21.87B 78.27%
2007-03-31 $27.26B $21.47B 78.75%
2006-12-31 $26.48B $20.92B 79.00%
2006-09-30 $25.61B $20.29B 79.23%
2006-06-30 $24.88B $19.66B 79.00%
2006-03-31 $24.39B $19.24B 78.89%
2005-12-31 $23.95B $18.59B 77.63%
2005-09-30 $23.46B $17.92B 76.37%
2005-06-30 $22.94B $17.38B 75.77%
2005-03-31 $22.10B $16.63B 75.27%
2004-12-31 $21.43B $16.28B 75.96%
2004-09-30 $20.50B $15.86B 77.36%
2004-06-30 $20.04B $15.48B 77.26%
2004-03-31 $19.19B $14.71B 76.66%
2003-12-31 $18.85B $14.38B 76.29%
2003-09-30 $18.87B $14.38B 76.20%
2003-06-30 $18.42B $13.92B 75.58%
2003-03-31 $18.37B $13.88B 75.58%
2002-12-31 $18.05B $13.53B 74.96%
2002-09-30 $17.59B $12.87B 73.17%
2002-06-30 $17.19B $12.59B 73.23%
2002-03-31 $16.91B $12.33B 72.89%
2001-12-31 $16.48B $11.99B 72.75%
2001-09-30 $16.18B $12.93B 79.92%
2001-06-30 $16.53B $14.34B 86.77%
2001-03-31 $16.40B $15.33B 93.45%
2000-12-31 $17.01B $17.01B 100.00%
2000-06-30 $13.11B $13.11B 100.00%
2000-03-31 $12.95B $12.95B 100.00%
1998-12-31 $15.40B $15.40B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $262.317B $54.073B
AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition of rare disease drugmaker, Alexion. The acquisition added Alexion's five marketed rare disease products and its pipeline of immune-mediated rare disease candidates.In order to bolster its respiratory portfolio, AstraZeneca acquired rights to Allergan's branded respiratory business in the U.S. and Canada in Mar 2015. The company also acquired Takeda's core respiratory business in May 2016.In June 2007, AstraZeneca acquired biotechnology company MedImmune. In Aug 2011, AstraZeneca sold its Astra Tech business to DENTSPLY. AstraZeneca entered into a number of deals and struck agreements with companies such as FibroGen and Daiichi Sankyo.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $172.422B 14.64
Gilead Sciences (GILD) United States $147.457B 14.51
Vertex Pharmaceuticals (VRTX) United States $103.890B 26.75
Bristol Myers Squibb (BMY) United States $95.049B 7.12
GSK (GSK) United Kingdom $94.678B 10.53
Regeneron Pharmaceuticals (REGN) United States $69.106B 17.93
Alnylam Pharmaceuticals (ALNY) United States $58.487B 1924.78
CSL (CSLLY) Australia $56.375B 0.00
Argenex SE (ARGX) Netherlands $52.620B 65.34
Insmed (INSM) United States $40.458B 0.00
Novozymes (NVZMY) Denmark $30.060B 0.00
BioNTech SE (BNTX) Germany $24.801B 0.00
Biogen (BIIB) United States $22.814B 9.29
Royalty Pharma (RPRX) United States $22.487B 8.53
Incyte (INCY) United States $20.806B 19.92
Genmab (GNMSF) Denmark $19.195B 14.08
Illumina (ILMN) United States $18.626B 27.96
Genmab (GMAB) Denmark $18.402B 13.85
Roivant Sciences (ROIV) United Kingdom $14.081B 0.00
Exact Sciences (EXAS) United States $12.539B 348.32
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Ascendis Pharma (ASND) Denmark $12.200B 0.00
Guardant Health (GH) United States $12.191B 0.00
Revolution Medicines (RVMD) United States $11.794B 0.00
Exelixis (EXEL) United States $10.942B 17.51
Avidity Biosciences (RNA) United States $10.190B 0.00
BioMarin Pharmaceutical (BMRN) United States $9.886B 17.93
QIAGEN (QGEN) Netherlands $9.683B 18.38
Moderna (MRNA) United States $9.587B 0.00
Bio-Techne Corp (TECH) United States $8.945B 33.38
Metsera (MTSR) United States $8.758B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.238B 29.62
Abivax SA (ABVX) France $8.193B 0.00
Repligen (RGEN) United States $8.039B 86.04
Halozyme Therapeutics (HALO) United States $8.025B 12.83
Jazz Pharmaceuticals (JAZZ) Ireland $7.970B 31.08
Cytokinetics (CYTK) United States $7.355B 0.00
Merus (MRUS) Netherlands $7.223B 0.00
Axsome Therapeutics (AXSM) United States $6.965B 0.00
Nuvalent (NUVL) United States $6.787B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.694B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.438B 0.00
Legend Biotech (LEGN) United States $5.869B 0.00
PTC Therapeutics (PTCT) United States $5.763B 7.83
Krystal Biotech (KRYS) United States $5.739B 29.67
Vaxcyte (PCVX) United States $5.452B 0.00
Alkermes (ALKS) Ireland $5.431B 15.97
Arrowhead Pharmaceuticals (ARWR) United States $5.424B 0.00
TG Therapeutics (TGTX) United States $5.118B 11.60
CRISPR Therapeutics AG (CRSP) Switzerland $5.013B 0.00
Arcellx (ACLX) United States $5.005B 0.00
Protagonist Therapeutics (PTGX) United States $4.973B 128.29
Zealand Pharma (ZLDPF) Denmark $4.769B 4.72
Akero Therapeutics (AKRO) United States $4.323B 0.00
Kymera Therapeutics (KYMR) United States $4.221B 0.00
Praxis Precision Medicines (PRAX) United States $4.207B 0.00
Viking Therapeutics (VKTX) United States $4.156B 0.00
Immunovant (IMVT) United States $4.070B 0.00
Ligand Pharmaceuticals (LGND) United States $3.968B 97.82
ACADIA Pharmaceuticals (ACAD) United States $3.818B 32.24
Belite Bio (BLTE) United States $3.604B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.500B 0.00
ADMA Biologics Inc (ADMA) United States $3.465B 24.61
Telix Pharmaceuticals (TLX) Australia $3.287B 0.00
Celcuity (CELC) United States $3.162B 0.00
CG Oncology (CGON) United States $3.026B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.968B 0.00
Ascentage Pharma Group - (AAPG) China $2.961B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.956B 0.00
Jyong Biotech (MENS) Taiwan $2.955B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.955B 0.00
Disc Medicine (IRON) United States $2.915B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.908B 85.27
Tarsus Pharmaceuticals (TARS) United States $2.897B 0.00
Travere Therapeutics (TVTX) United States $2.894B 0.00
GRAIL (GRAL) United States $2.862B 0.00
Scholar Rock Holding (SRRK) United States $2.783B 0.00
Amicus Therapeutics (FOLD) United States $2.737B 221.75
IDEAYA Biosciences (IDYA) United States $2.651B 0.00
Cidara Therapeutics (CDTX) United States $2.647B 0.00
Viridian Therapeutics (VRDN) United States $2.619B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.608B 0.00
Apogee Therapeutics (APGE) United States $2.523B 0.00
Mineralys Therapeutics (MLYS) United States $2.521B 0.00
Anbio Biotechnology (NNNN) Germany $2.461B 0.00
Zai Lab (ZLAB) China $2.448B 0.00
Apellis Pharmaceuticals (APLS) United States $2.437B 62.13
Agios Pharmaceuticals (AGIO) United States $2.372B 0.00
Bavarian Nordic (BVNRY) Denmark $2.308B 11.16
Liquidia (LQDA) United States $2.270B 0.00
Adaptive Biotechnologies (ADPT) United States $2.258B 0.00
Beam Therapeutics (BEAM) United States $2.254B 0.00
Denali Therapeutics (DNLI) United States $2.203B 0.00
ImmunityBio (IBRX) United States $2.098B 0.00
Arcus Biosciences (RCUS) United States $2.085B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.006B 0.00
Vericel (VCEL) United States $1.969B 162.25
ANI Pharmaceuticals (ANIP) United States $1.962B 15.75
Structure Therapeutics (GPCR) United States $1.892B 0.00
Mesoblast (MESO) Australia $1.874B 0.00
Twist Bioscience (TWST) United States $1.827B 0.00
Edgewise Therapeutics (EWTX) United States $1.817B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.810B 9.88
MannKind (MNKD) United States $1.729B 56.30
Sarepta Therapeutics (SRPT) United States $1.723B 0.00
Alvotech (ALVO) Luxembourg $1.721B 12.98
Immunocore Holdings (IMCR) United Kingdom $1.688B 0.00
Cogent Biosciences (COGT) United States $1.687B 0.00
Nuvation Bio (NUVB) United States $1.622B 0.00
Terns Pharmaceuticals (TERN) United States $1.616B 0.00
Janux Therapeutics (JANX) United States $1.591B 0.00
Sionna Therapeutics (SION) United States $1.549B 0.00
Vera Therapeutics (VERA) United States $1.544B 0.00
UniQure (QURE) Netherlands $1.525B 0.00
Celldex Therapeutics (CLDX) United States $1.521B 0.00
Zenas BioPharma (ZBIO) United States $1.415B 0.00
Certara (CERT) United States $1.393B 25.50
Maze Therapeutics (MAZE) United States $1.375B 0.00
Spyre Therapeutics (SYRE) United States $1.360B 0.00
Trevi Therapeutics (TRVI) United States $1.341B 0.00
Immunome (IMNM) United States $1.327B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.307B 0.00
Stoke Therapeutics (STOK) United States $1.306B 34.12
NeoGenomics (NEO) United States $1.304B 0.00
Dynavax Technologies (DVAX) United States $1.272B 37.35
WAVE Life Sciences (WVE) Singapore $1.251B 0.00
Upstream Bio (UPB) United States $1.241B 0.00
Zymeworks (ZYME) United States $1.237B 0.00
NovoCure (NVCR) Jersey $1.223B 0.00
Novavax (NVAX) United States $1.209B 3.07
Oric Pharmaceuticals (ORIC) United States $1.199B 0.00
Inhibrx Biosciences (INBX) United States $1.169B 0.00
CureVac (CVAC) Germany $1.169B 5.43
AbCellera Biologics (ABCL) Canada $1.168B 0.00
Dianthus Therapeutics (DNTH) United States $1.168B 0.00
Precigen (PGEN) United States $1.162B 0.00
Pharvaris (PHVS) Netherlands $1.129B 0.00
MiMedx (MDXG) United States $1.102B 19.58
Immatics (IMTX) Germany $1.100B 0.00
AnaptysBio (ANAB) United States $1.098B 0.00
Urogen Pharma (URGN) United States $1.088B 0.00
Tango Therapeutics (TNGX) United States $1.059B 0.00
Pharming Group (PHAR) Netherlands $1.057B 0.00
Fortrea Holdings (FTRE) United States $1.040B 22.06
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Intellia Therapeutics (NTLA) United States $1.022B 0.00
Oculis Holding AG (OCS) Switzerland $1.007B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.999B 0.00
Pacira BioSciences (PCRX) United States $0.991B 10.86
Rezolute (RZLT) United States $0.977B 0.00
Sana Biotechnology (SANA) United States $0.973B 0.00
Castle Biosciences (CSTL) United States $0.964B 132.16
BridgeBio Oncology Therapeutics (BBOT) United States $0.962B 0.00
Nanobiotix S.A - (NBTX) France $0.953B 0.00
Nurix Therapeutics (NRIX) United States $0.946B 0.00
BGM Group (BGM) China $0.943B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.943B 0.00
Rapport Therapeutics (RAPP) United States $0.937B 0.00
Kodiak Sciences (KOD) United States $0.931B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.928B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Iovance Biotherapeutics (IOVA) United States $0.913B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.890B 0.00
Biohaven (BHVN) United States $0.874B 0.00
Arbutus Biopharma (ABUS) United States $0.863B 0.00
Palvella Therapeutics (PVLA) United States $0.861B 0.00
MBX Biosciences (MBX) United States $0.859B 0.00
Kura Oncology (KURA) United States $0.858B 0.00
CorMedix Inc (CRMD) United States $0.843B 14.35
Septerna (SEPN) United States $0.825B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.802B 38.47
Bicara Therapeutics (BCAX) United States $0.800B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.790B 0.00
Tyra Biosciences (TYRA) United States $0.764B 0.00
ArriVent BioPharma (AVBP) United States $0.732B 0.00
LENZ Therapeutics (LENZ) United States $0.719B 0.00
Vir Biotechnology (VIR) United States $0.714B 0.00
Astria Therapeutics (ATXS) United States $0.706B 0.00
GH Research (GHRS) Ireland $0.702B 0.00
Gyre Therapeutics (GYRE) United States $0.694B 90.12
MoonLake Immunotherapeutics (MLTX) Switzerland $0.683B 0.00
Arvinas (ARVN) United States $0.683B 0.00
Geron (GERN) United States $0.683B 0.00
MeiraGTx Holdings (MGTX) United States $0.681B 0.00
Replimune (REPL) United States $0.652B 0.00
MapLight Therapeutics (MPLT) $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Erasca (ERAS) United States $0.644B 0.00
Anavex Life Sciences (AVXL) United States $0.626B 0.00
Ventyx Biosciences (VTYX) United States $0.625B 0.00
CytomX Therapeutics (CTMX) United States $0.613B 9.05
Cytek Biosciences (CTKB) United States $0.591B 0.00
Myriad Genetics (MYGN) United States $0.587B 0.00
Compass Therapeutics (CMPX) United States $0.585B 0.00
Opthea (OPT) Australia $0.583B 0.00
Olema Pharmaceuticals (OLMA) United States $0.573B 0.00
Prothena (PRTA) Ireland $0.568B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.568B 0.00
REGENXBIO (RGNX) United States $0.567B 0.00
Inventiva S.A (IVA) France $0.558B 0.00
Gossamer Bio (GOSS) United States $0.546B 0.00
Niagen Bioscience (NAGE) United States $0.546B 42.75
Verastem (VSTM) United States $0.539B 0.00
Emergent Biosolutions (EBS) United States $0.534B 5.13
Ginkgo Bioworks Holdings (DNA) United States $0.530B 0.00
Prime Medicine (PRME) United States $0.513B 0.00
Monopar Therapeutics (MNPR) United States $0.499B 0.00
Absci (ABSI) United States $0.499B 0.00
Keros Therapeutics (KROS) United States $0.494B 10.52
Alumis (ALMS) United States $0.491B 0.00
Rapt Therapeutics (RAPT) United States $0.477B 0.00
DBV Technologies S.A (DBVT) France $0.473B 0.00
NovaBridge Biosciences (NBP) United States $0.461B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.455B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.454B 0.00
Eton Pharmaceuticals (ETON) United States $0.453B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.446B 0.00
Design Therapeutics (DSGN) United States $0.431B 0.00
Cullinan Therapeutics (CGEM) United States $0.425B 0.00
Ocugen (OCGN) United States $0.425B 0.00
PureTech Health (PRTC) United States $0.423B 0.00
Neumora Therapeutics (NMRA) United States $0.415B 0.00
Bright Minds Biosciences (DRUG) United States $0.414B 0.00
Fulcrum Therapeutics (FULC) United States $0.413B 0.00
XOMA Royalty (XOMA) United States $0.401B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.388B 0.00
Kamada (KMDA) Israel $0.383B 19.59
Neurogene (NGNE) United States $0.382B 0.00
Northwest Biotherapeutics (NWBO) United States $0.375B 0.00
Invivyd (IVVD) United States $0.370B 0.00
Tectonic Therapeutic (TECX) United States $0.362B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.354B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.343B 0.00
Benitec Biopharma (BNTC) United States $0.336B 0.00
Aura Biosciences (AURA) United States $0.332B 0.00
AC Immune (ACIU) Switzerland $0.331B 0.00
Amarin (AMRN) Ireland $0.325B 0.00
Contineum Therapeutics (CTNM) United States $0.319B 0.00
Annexon (ANNX) United States $0.316B 0.00
Solid Biosciences (SLDB) United States $0.316B 0.00
Alto Neuroscience (ANRO) United States $0.313B 0.00
EnGene Holdings (ENGN) Canada $0.310B 0.00
DiaMedica Therapeutics (DMAC) United States $0.306B 0.00
Puma Biotechnology (PBYI) United States $0.302B 8.09
Jade Biosciences (JBIO) United States $0.300B 0.00
Immuneering (IMRX) United States $0.286B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.286B 0.00
Kyverna Therapeutics (KYTX) United States $0.285B 0.00
Candel Therapeutics (CADL) United States $0.277B 0.00
Allogene Therapeutics (ALLO) United States $0.265B 0.00
Entrada Therapeutics (TRDA) United States $0.264B 0.00
BioAge Labs (BIOA) United States $0.260B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.260B 0.00
Atea Pharmaceuticals (AVIR) United States $0.260B 0.00
Lifecore Biomedical (LFCR) United States $0.257B 0.00
Alpha Teknova (TKNO) United States $0.252B 0.00
Prima BioMed (IMMP) Australia $0.249B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Sagimet Biosciences (SGMT) United States $0.245B 0.00
Zura Bio (ZURA) United States $0.239B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.237B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.235B 0.00
Voyager Therapeutics (VYGR) United States $0.235B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.234B 0.00
Cabaletta Bio (CABA) United States $0.233B 0.00
Adherex Technologies (FENC) United States $0.224B 0.00
Palisade Bio (PALI) United States $0.223B 0.00
Editas Medicine (EDIT) United States $0.222B 0.00
Black Diamond Therapeutics (BDTX) United States $0.222B 10.81
Aardvark Therapeutics (AARD) United States $0.220B 0.00
Adocia (ADOCY) France $0.216B 0.00
Abeona Therapeutics (ABEO) United States $0.215B 4.57
Orchestra BioMed Holdings (OBIO) United States $0.215B 0.00
Humacyte (HUMA) United States $0.211B 0.00
Tenaya Therapeutics (TNYA) United States $0.209B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.208B 0.00
Genelux (GNLX) United States $0.206B 0.00
Cartesian Therapeutics (RNAC) United States $0.205B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.204B 0.00
SELLAS Life Sciences (SLS) United States $0.199B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.196B 0.00
Caribou Biosciences (CRBU) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.195B 0.00
Molecular Partners AG (MOLN) Switzerland $0.191B 0.00
Nautilus Biotechnology (NAUT) United States $0.191B 0.00
Crescent Biopharma (CBIO) United States $0.182B 0.00
C4 Therapeutics (CCCC) United States $0.167B 0.00
Innate Pharma S.A (IPHA) France $0.164B 0.00
Coherus Oncology (CHRS) United States $0.162B 0.00
Sangamo Therapeutics (SGMO) United States $0.159B 0.00
Nuvectis Pharma (NVCT) United States $0.157B 0.00
MaxCyte (MXCT) United States $0.154B 0.00
Codexis (CDXS) United States $0.153B 0.00
PepGen (PEPG) United States $0.152B 0.00
Forte Biosciences (FBRX) United States $0.150B 0.00
Cognition Therapeutics (CGTX) United States $0.147B 0.00
Cardiff Oncology (CRDF) United States $0.146B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.145B 0.00
Rani Therapeutics Holdings (RANI) United States $0.145B 0.00
Elicio Therapeutics (ELTX) United States $0.145B 0.00
Compugen (CGEN) Israel $0.145B 0.00
Entera Bio (ENTX) Israel $0.143B 0.00
Actuate Therapeutics (ACTU) United States $0.143B 0.00
Scilex Holding (SCLX) United States $0.143B 0.00
Anika Therapeutics (ANIK) United States $0.142B 0.00
Alector (ALEC) United States $0.140B 0.00
Nkarta (NKTX) United States $0.139B 0.00
Spero Therapeutics (SPRO) United States $0.138B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.138B 0.00
Opus Genetics (IRD) United States $0.130B 0.00
TuHURA Biosciences (HURA) United States $0.129B 0.00
Vor Biopharma (VOR) $0.128B 0.00
Seres Therapeutics (MCRB) United States $0.127B 0.00
Agenus (AGEN) United States $0.127B 0.00
Climb Bio (CLYM) United States $0.125B 0.00
Fate Therapeutics (FATE) United States $0.123B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.123B 0.00
VistaGen Therapeutics (VTGN) United States $0.122B 0.00
Applied Therapeutics (APLT) United States $0.122B 0.00
Greenwich LifeSciences (GLSI) United States $0.120B 0.00
Alpha Cognition (ACOG) Canada $0.120B 0.00
Seer (SEER) United States $0.118B 0.00
EXoZymes (EXOZ) United States $0.117B 0.00
BioHarvest Sciences (BHST) Canada $0.117B 0.00
Citius Oncology (CTOR) United States $0.117B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.114B 0.00
Inovio Pharmaceuticals (INO) United States $0.113B 0.00
Turn Therapeutics (TTRX) United States $0.113B 0.00
Estrella Immunopharma (ESLA) United States $0.109B 0.00
Immix Biopharma (IMMX) United States $0.104B 0.00
VTv Therapeutics (VTVT) United States $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.102B 0.00
Instil Bio (TIL) United States $0.102B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.099B 0.00
Clene (CLNN) United States $0.099B 0.00
Pliant Therapeutics (PLRX) United States $0.098B 0.00
Tevogen Bio Holdings (TVGN) United States $0.098B 0.00
Whitehawk Therapeutics (WHWK) United States $0.098B 0.00
Biomea Fusion (BMEA) United States $0.097B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.097B 0.00
Coya Therapeutics (COYA) United States $0.096B 0.00
Starpharma Holdings (SPHRY) Australia $0.096B 0.00
Shattuck Labs (STTK) United States $0.095B 0.00
Ovid Therapeutics (OVID) United States $0.094B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.092B 0.00
OKYO Pharma (OKYO) $0.092B 0.00
Adverum Biotechnologies (ADVM) United States $0.091B 0.00
23andMe Holding (MEHCQ) United States $0.090B 0.00
Kalaris Therapeutics (KLRS) United States $0.089B 0.00
Connect Biopharma Holdings (CNTB) United States $0.086B 0.00
CAMP4 Therapeutics (CAMP) United States $0.086B 0.00
Artiva Biotherapeutics (ARTV) United States $0.085B 0.00
Quince Therapeutics (QNCX) United States $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.083B 0.00
InflaRx (IFRX) Germany $0.083B 0.00
Precision BioSciences (DTIL) United States $0.081B 0.00
ATyr Pharma (ATYR) United States $0.080B 0.00
BeyondSpring (BYSI) United States $0.079B 0.00
Fortress Biotech (FBIO) United States $0.078B 0.00
ALX Oncology Holdings (ALXO) United States $0.074B 0.00
Repare Therapeutics (RPTX) Canada $0.073B 0.00
XBiotech (XBIT) United States $0.071B 0.00
Immunic (IMUX) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.071B 0.00
Sutro Biopharma (STRO) United States $0.070B 0.00
Adagene (ADAG) China $0.066B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.066B 0.00
Equillium (EQ) United States $0.065B 0.00
CervoMed (CRVO) United States $0.064B 0.00
Spruce Biosciences (SPRB) United States $0.064B 0.00
BioStem Technologies (BSEM) $0.062B 3.26
TScan Therapeutics (TCRX) United States $0.062B 0.00
MiNK Therapeutics (INKT) United States $0.060B 0.00
Adlai Nortye (ANL) Cayman Islands $0.057B 0.00
Werewolf Therapeutics (HOWL) United States $0.056B 0.00
Cue Biopharma (CUE) United States $0.054B 0.00
Adicet Bio (ACET) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
Senti Biosciences (SNTI) United States $0.051B 0.00
Annovis Bio (ANVS) United States $0.049B 0.00
Celularity (CELU) United States $0.048B 0.00
Skye Bioscience (SKYE) United States $0.047B 0.00
TELA Bio (TELA) United States $0.046B 0.00
Radiopharm Theranostics - (RADX) Australia $0.046B 0.00
Hyperion DeFi (HYPD) United States $0.045B 0.00
Kezar Life Sciences (KZR) United States $0.044B 0.00
Genenta Science S.p.A (GNTA) Italy $0.044B 0.00
CalciMedica (CALC) United States $0.044B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.043B 0.00
INmune Bio (INMB) United States $0.043B 0.00
PDS Biotechnology (PDSB) United States $0.043B 0.00
Medicus Pharma (MDCX) United States $0.043B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.042B 0.00
X4 Pharmaceuticals (XFOR) United States $0.042B 0.00
Mersana Therapeutics (MRSN) United States $0.042B 0.00
Xilio Therapeutics (XLO) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
BioAtla (BCAB) United States $0.040B 0.00
OnKure Therapeutics (OKUR) United States $0.040B 0.00
Elutia (ELUT) United States $0.038B 0.00
Tvardi Therapeutics (TVRD) United States $0.038B 0.00
Rein Therapeutics (RNTX) United States $0.037B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
RenovoRx (RNXT) United States $0.035B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.034B 0.00
Generation Bio (GBIO) United States $0.034B 0.00
Quantum Biopharma (QNTM) Canada $0.034B 0.00
Femasys (FEMY) United States $0.034B 0.00
Dyadic (DYAI) United States $0.034B 0.00
SAB Biotherapeutics (SABS) United States $0.033B 0.00
ImageneBio (IMA) United States $0.033B 0.00
Tenax Therapeutics (TENX) United States $0.032B 0.00
Tharimmune (THAR) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
BioXcel Therapeutics (BTAI) United States $0.029B 0.00
Synaptogenix (TAOX) United States $0.029B 0.00
Jasper Therapeutics (JSPR) United States $0.029B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
Q32 Bio (QTTB) United States $0.028B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
Pluri (PLUR) Israel $0.027B 0.00
IBio (IBIO) United States $0.027B 0.00
Rallybio (RLYB) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.025B 0.00
Intensity Therapeutics (INTS) United States $0.025B 0.00
Exicure (XCUR) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.024B 0.00
Moleculin Biotech (MBRX) United States $0.024B 0.00
NextCure (NXTC) United States $0.024B 0.00
Lexaria Bioscience (LEXX) Canada $0.023B 0.00
MetaVia (MTVA) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.020B 0.00
Cingulate (CING) United States $0.020B 0.00
Passage Bio (PASG) United States $0.020B 0.00
Clearside Biomedical (CLSD) United States $0.019B 0.00
Leap Therapeutics (LPTX) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
NewcelX (NCEL) Switzerland $0.018B 0.00
FibroBiologics (FBLG) United States $0.018B 0.00
Lisata Therapeutics (LSTA) United States $0.018B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
Curis (CRIS) United States $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Apollomics (APLM) United States $0.016B 0.00
Longeveron (LGVN) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Revelation Biosciences (REVB) United States $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
BioCardia (BCDA) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.014B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.013B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Dogwood Therapeutics (DWTX) United States $0.012B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Purple Biotech (PPBT) Israel $0.011B 0.00
Imunon (IMNN) United States $0.010B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.010B 0.00
Gelteq (GELS) Australia $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
BRIACELL THERAP (BCTX) Canada $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Aprea Therapeutics (APRE) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Bionano Genomics (BNGO) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Black Titan (BTTC) United States $0.004B 0.00
Psyence Biomedical (PBM) Canada $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Alps Group (ALPS) United States $0.003B 2.21
GT Biopharma (GTBP) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00